Skip to content

Impact of fatty meal co-administration and dual-dosing on albendazole effectiveness against hookworm among school-aged children in Mayuge district, Uganda

Impact of fatty meal co-administration and dual-dosing on albendazole effectiveness against hookworm among school-aged children in Mayuge district, Uganda

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202202738940158
Enrollment
210
Registered
2022-02-01
Start date
2022-02-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soil-transmitted helminth, hookworm infection

Interventions

single dose albendazole with avocado
Single dose albendazole without taking avocado
Dual dose albendazole without taking avocado
Dual dose albendazole with taking avocado

Sponsors

World Vision Uganda
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Children identified with hookworm infection in the January 2022 prevalence survey 2) Children attending randomly selected P4 and P5 classes in one of the randomly selected schools 3) Children whose parents/guardians provide written informed consent for the prevalence survey and for the nested trial if hookworm infection is detected.

Exclusion criteria

Exclusion criteria: 1) Children who received benzimidazole drugs such as albendazole and mebendazole within three months before the prevalence survey to avoid the residual effect of previously administrated drugs of albendazole. 2) Children who have a history of allergic reaction to albendazole or other benzimidazole drugs such as mebendazole.

Design outcomes

Primary

MeasureTime frame
Cure rate The cure rate (CR) is defined as the percentage of infected individuals at prevalence survey that are free of infection three weeks after treatment. ;Egg reduction rate (ERR) Egg per gram (EPG): With the Kato-Katz method, the measure of EPG is obtained by multiplying the number of eggs counted on the slide. Considering the slide template holds 41.7mg of faeces, the multiplication factor to obtain EPG is 24.

Secondary

MeasureTime frame
Adverse events from the clinical trial

Countries

Uganda

Contacts

Public ContactBomax Otim

Project coordinator

Bomx_Otim@wvi.org+256755002670

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026